FQL
  • Scope project:Oncolinq
  • Readonly

If you Log in or sign up, you can edit this script yourself.

Hi there. Nice to see you here!

This is the FQL playground. But you can use FQL everywhere in Simplifier and Firely Terminal. You can use it to create tables in your own documentation and implementation guides.

Read the documentation here.

OK. Thanks

With FQL you can:

  • Run custom queries over your FHIR meta data
  • Gain insight
  • Check for quality and consistency
  • Create custom tables in your documentation
nametypekindurl
aantal_lymfeklieren_met_geisoleerde_tumorcellen_swkObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-149
aantal_lymfeklieren_met_macrometastasen_swkObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-150
aantal_lymfeklieren_met_micrometastasen_swkObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-148
aantal_swksObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-147
afwijkingObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-486
carcinoma_in_situObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-447
diameterObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-450
eerdere_niet_complete_excisieObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-534
eerdere_therapieObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-533
erpercentageObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-138
erstatusObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-139
graad_539Observationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-539
her2_cishsishObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-628
her2_fishObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-627
her2_immunohistochemieObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-626
her2_pcrObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-629
her2statusObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-142
histologie_excisiepreparaat_borstObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-632
histologie_lymfeklierenObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-495
histologie_schildwachtklier_borstObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-144
invasief_carcinoomObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-127
lokalisatieObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-537
mammaprintObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-474
naam_protocolExtensioncomplex-typehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-480
oncotype_dxObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-475
p_nObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-468
p_tObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-491
preparaatObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-532
prpercentageObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-140
prstatusObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-141
receptor_status_postoperatiefObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-137
snijvlakObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-458
tnummerExtensionresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-479
totaal_aantal_axillaire_lymfeklieren_met_micro_enof_macrometastasenObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-631
totaal_aantal_onderzochte_klierenObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-540
tumor_aanwezigObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-535
tumorrest_aanwezigObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-488
tweede_of_derde_tumorObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-536
type_afwijkingObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-487
type_carcinoma_in_situObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-452
type_carcinoma_in_situ_andersObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-462
type_invasief_carcinoomObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-460
type_invasief_carcinoom_andersObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-461
type_invasieve_tumor_overigObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-538
uitslag_mammacarcinoomtotaal_naar_nkrDiagnosticReportresourcehttp://www.iknl.nl/fhir/StructureDefinition/uitslag_mammacarcinoomtotaal_naar_nkr
versie_protocolExtensioncomplex-typehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-543
versienummer_verslagExtensioncomplex-typehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-547
zijdigheidObservationresourcehttp://www.iknl.nl/fhir/StructureDefinition/onco-mamma-dataelement-531